
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
GPI CRISPR/Cas9 KO Plasmid (h) | sc-402796 | 20 µg | $397.00 |
Glucose-6-phosphate isomerase (GPI) is a multifunctional enzyme that catalyzes the reversible interconversion of glucose-6-phosphate and fructose-6-phosphate, a central step linking glycolysis and gluconeogenesis. By controlling carbon flux through these pathways, GPI influences cellular ATP production, biosynthetic precursor availability, and redox balance, thereby shaping metabolic adaptation under stress. Beyond its cytosolic metabolic role, GPI has been reported to participate in extracellular signaling contexts, connecting metabolism with cell motility and microenvironmental interactions. Altered GPI activity or expression is associated with metabolic dysregulation and has been studied in contexts including anemia due to inherited enzyme deficiency and metabolic remodeling observed in proliferative disease models.
GPI CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the GPI gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the GPI together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the GPI open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish GPI protein expression.
This CRISPR knockout system enables efficient generation of GPI-deficient cell models for investigation of GPI signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.